Document Detail


Sugammadex: a novel approach to reversal of neuromuscular blockade.
MedLine Citation:
PMID:  21306205     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Sugammadex is the first in a new class of medications termed selective relaxant binding agents. This medication acts to encapsulate free circulating steroidal nondepolarizing neuromuscular blocking agents. The encapsulation of neuromuscular agents effectively decreases the amount of neuromuscular blocker interacting at the neuromuscular receptor. This binding has a very high association rate, rendering the incidence of residual block extremely low, while avoiding the side effects associated with traditional reversal agents. Currently approved for clinical use in over 50 countries, sugammadex was not approved by the US FDA in 2008 due to concerns over potential hypersensitivity reactions. It is hoped that further study and clinical experience will help to better define the risk associated with sugammadex and eventually lead to the approval of this novel medication in the USA.
Authors:
Stephen Aniskevich; Bruce J Leone; Sorin J Brull
Related Documents :
21993045 - Impact of wireless electronic medical record system on the quality of patient documenta...
21268095 - Donor survey to assess facial flushing during automated red cell collections and medica...
16310345 - Assessing the quantitative reliability of solid-state 13c nmr spectra of kerogens acros...
12500515 - Reflex responses to insertion of the intubating laryngeal mask airway, intubation and r...
17450685 - Recent consensus on the classification of rhinosinusitis--a way forward for research an...
6464645 - Ultrastructural changes and proliferation of pituicytes in mouse posterior lobe during ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of neurotherapeutics     Volume:  11     ISSN:  1744-8360     ISO Abbreviation:  Expert Rev Neurother     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101129944     Medline TA:  Expert Rev Neurother     Country:  England    
Other Details:
Languages:  eng     Pagination:  185-98     Citation Subset:  IM    
Affiliation:
Mayo Clinic, Department of Anesthesiology, 4500 San Pablo Rd, Jacksonville, FL 32224, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Epigenetic Gene Silencing is a Novel Mechanism Involved in Delayed Manifestation of Radiation-Induce...
Next Document:  Recent advances in basic and translational stroke research.